News of Note—Anthem will cover artificial pancreas; Takeda posts update on depression-monitoring smartwatch study

newspaper

> Anthem, the second-largest insurance company nationwide, will cover artificial pancreas systems. Drug Delivery Business News story

> Takeda and Cognition Kit reported strong compliance in 30-person trial investigating the use of the Apple Watch to monitor people with major depressive disorder. Release | Read more from FierceMedTech

> The FDA cleared Kaléo’s AUVI-Q 0.1 mg Auto-injector, the first and only epinephrine autoinjector designed to treat allergic reactions in infants and small children. Release

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.